Find Affordable Addiction Treatment Centers Massachusetts.
Find affordable addiction treatment centers Massachusetts. – www.drugrehabvideo.com If youre from Massachusetts and are seeking addiction treatment centers, look no further. Rehabilitation can be tough on your own. A full staff of caring professionals will make sure you reach your goals. Defeat substance abuse and start your new life with addiction treatment centers outside of MA. Call 866 858-6003 today.
Fungal Meningitis Outbreak Leaves Lasting Scar on 2012
Filed under: drug treatment centers in massachusetts
Dr. Graf Hilgenhurst prepares to give an epidural treatment to a woman with back pain. Photo credit Blake Farmer/WPLN … He died at Vanderbilt University Medical Center before doctors really knew what they were dealing with. Like 367 families with a …
Read more on Nashville Public Radio
New whole plant therapy shows promise as an effective and economical …
Filed under: drug treatment centers in massachusetts
In the worldwide battle to curtail malaria, one of the most prevalent and deadly infectious diseases of the developing world, drug after drug has fallen by the wayside as the malaria parasite has become resistant to it. … A new study by scientists at …
Read more on EurekAlert (press release)
Meningitis Outbreak Sparks Call For New FDA Regulations On Drug …
Filed under: drug treatment centers in massachusetts
In one of the biggest U.S. public health crises, 620 people in 19 states since mid-September have contracted fungal meningitis traced to epidural injections for back and joint pain produced by Massachusetts-based New England Compounding Center …
Read more on Huffington Post
FDA, industry push to tweak accelerated approval pathway likely to have …
Filed under: drug treatment centers in massachusetts
A US Food and Drug Administration (FDA) plan to hasten approvals and improve FDA-industry coordination will likely have minor impact on mid-to-large pharma, four drug industry consultants told BioPharm Insight. FDA is … who moderated the panel: use …
Read more on Financial Times